Nuwellis Inc vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Nuwellis Inc trades at $1.48 (market cap $542.80K), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $39.58. The key difference: YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | QDTY | |
|---|---|---|
Market Cap | $542.80K | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $220.50 | $46.71 |
52-Week Low | $1.42 | $36.57 |
Enterprise Value | -$1.27M | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
QDTY trades at $39.78, up 1.02% today, with a bearish technical signal from moving averages and mixed oscillators. The stock shows consistent weekly dividend distributions, but key valuation and profitability ratios are unavailable. Recent news highlights ongoing dividend announcements from YieldMax ETFs, indicating a focus on income generation.
The outlook is cautious due to bearish technicals and lack of fundamental data; risks include market volatility and dependency on dividend strategy. Investors should seek updated financials for a clearer assessment of growth potential and sustainability.
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.
Read more on QDTY →